Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102500 · ClinicalTrials.gov registry record
Second Opinions in Oncology
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 236
- Enrollment target
NCT05102500: Completed study, sponsored by University of Colorado, Denver.
NCT05102500 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 236 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05102500 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 236 participants
- Enrollment target
Study Summary
The long-time goal is to understand what decision-making process and patient characteristics factor into a patient deciding to stay with their initial physician versus seeking treatment with a second opinion.
Primary Outcome
a. The study team will perform a retrospective chart review to identify patients with breast cancer, colorectal cancer or pancreatic cancer who were seen by a surgeon at the University of Colorado for a second opinion and to examine whether or not the subject stayed at the Cancer Center to receive cancer care. The study team predict the second opinion retention rate - the percent of patients who received a second opinion at the Cancer Center and ultimately received care at this institution - wil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2021-05-14 |
| Est. Completion | 2024-05-10 |
What the finished NCT05102500 record still lists
NCT05102500 is an observational study that tracks outcomes without assigning an intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05102500 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05102500 about?
NCT05102500 is a clinical study titled "Second Opinions in Oncology". The long-time goal is to understand what decision-making process and patient characteristics factor into a patient deciding to stay with their initial physician versus seeking treatment with a second opinion.
What is the current status of trial NCT05102500?
This trial is currently completed. The enrollment target is 236 participants. The study started on 2021-05-14. Estimated completion is 2024-05-10.
Who is sponsoring clinical trial NCT05102500?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04995341 · 236 participants · NA
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
- NCT05822362 · 236 participants · Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
- NCT06200103 · 236 participants · Phase 2
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- NCT06494072 · 236 participants · Phase 4
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI